CoChat

A radiomic signature as a non-invasive predictor of progression-free survival in patients with lower-grade gliomas

Open access
Liu, Xing, Li, Yiming, Qian, Zenghui, Sun, Zhiyan, Xu, Kaibin, Wang, Kai, Liu, Shuai, Fan, Xing, Li, Shaowu, Zhang, Zhong, Jiang, Tao, Wang, Yinyan · 2018 · NeuroImage: Clinical
Cited by 245

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: The aim of this study was to develop a radiomics signature for prediction of progression-free survival (PFS) in lower-grade gliomas and to investigate the genetic background behind the radiomics signature. METHODS: In this retrospective study, training (n = 216) and validation (n = 84) cohorts were collected from the Chinese Glioma Genome Atlas and the Cancer Genome Atlas, respectively. For each patient, a total of 431 radiomics features were extracted from preoperative T2-weighted magnetic resonance images. A radiomics signature was generated in the training cohort, and its prognostic value was evaluated in both the training and validation cohorts. The genetic characteristics of the group with high-risk scores were identified by radiogenomic analysis, and a nomogram was established for prediction of PFS. RESULTS: There was a significant association between the radiomics signature (including 9 screened radiomics features) and PFS, which was independent of other clinicopathologic factors in both the training (P < 0.001, multivariable Cox regression) and validation (P = 0.045, multivariable Cox regression) cohorts. Radiogenomic analysis revealed that the radiomics signature was associated with the immune response, programmed cell death, cell proliferation, and vasculature development. A nomogram established using the radiomics signature and clinicopathologic risk factors demonstrated high accuracy and good calibration for prediction of PFS in both the training (C-index, 0.684) and validation (C-index, 0.823) cohorts. CONCLUSIONS: PFS can be predicted non-invasively in patients with LGGs by a group of radiomics features that could reflect the biological processes of these tumors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.nicl.2018.10.014

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 245

Metadata

Authors
Liu, X., Li, Y., Qian, Z., Sun, Z., Xu, K., Wang, K., Liu, S., Fan, X., Li, S., Zhang, Z., Jiang, T., & Wang, Y.
Venue
NeuroImage: Clinical
Publisher
Elsevier BV
Published
2018
Volume
20
Pages
1070-1077
ISSN
2213-1582 (ISSN-L)
OpenAlex
W2897228009
Cited by
245
References
4
FWCI
12.13
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A radiomic signature as a non-invasive predictor of progression-free survival in patients with lower-grade gliomas. https://app.cochat.ai/papers/10.1016/j.nicl.2018.10.014
The paper
Liu, X., Li, Y., Qian, Z., Sun, Z., Xu, K., Wang, K., Liu, S., Fan, X., Li, S., Zhang, Z., Jiang, T., & Wang, Y. (2018). A radiomic signature as a non-invasive predictor of progression-free survival in patients with lower-grade gliomas. NeuroImage: Clinical. https://doi.org/10.1016/j.nicl.2018.10.014

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.